Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,183,680
+$314,956 QoQ
Shares Held
17,536
-25.4% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 211 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $888,562,834 across 167 Biotechnology names. ANAB ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
729,635 | $219,642,024 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,938,035 | $151,689,999 | |
| 3 | CAI |
Caris Life Sciences, Inc.
|
3,958,531 | $70,541,022 | |
| 4 | INCY |
Incyte Corp
|
578,986 | $65,633,852 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
130,802 | $64,973,277 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,159,457 | $63,086,055 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
98,585 | $61,471,690 | |
| 8 | RPRX |
Royalty Pharma plc
|
877,674 | $49,211,181 |
All Filings in ANAB
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,183,680 | 17,536 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $868,724 | 15,664 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $732,096 | 15,101 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $455,502 | 14,876 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $333,599 | 15,027 | Shares | Sole | 2025-08-07 | |
| 2022-06-30 | $421,893 | 20,783 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $2,612,810 | 105,611 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,235,892 | 121,896 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $3,540,787 | 130,560 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $3,272,501 | 126,205 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $1,638,450 | 76,030 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $222,954 | 10,370 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $324,793 | 22,020 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $440,543 | 19,720 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $163,201 | 11,550 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||